Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) EBITDA (2020 - 2025)

Historic EBITDA for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $15.7 million.

  • Alignment Healthcare's EBITDA rose 22546.85% to $15.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.3 million, marking a year-over-year increase of 13085.45%. This contributed to the annual value of -$75.2 million for FY2024, which is 2931.14% up from last year.
  • Alignment Healthcare's EBITDA amounted to $15.7 million in Q3 2025, which was up 22546.85% from $29.8 million recorded in Q2 2025.
  • In the past 5 years, Alignment Healthcare's EBITDA registered a high of $29.8 million during Q2 2025, and its lowest value of -$49.0 million during Q1 2021.
  • In the last 5 years, Alignment Healthcare's EBITDA had a median value of -$27.6 million in 2023 and averaged -$21.8 million.
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 310609.04% in 2021, then surged by 35100.29% in 2025.
  • Quarter analysis of 5 years shows Alignment Healthcare's EBITDA stood at -$39.4 million in 2021, then fell by 20.4% to -$47.5 million in 2022, then increased by 23.97% to -$36.1 million in 2023, then surged by 56.38% to -$15.7 million in 2024, then skyrocketed by 199.55% to $15.7 million in 2025.
  • Its last three reported values are $15.7 million in Q3 2025, $29.8 million for Q2 2025, and $1.6 million during Q1 2025.